Editas Medicine, Inc.
EDIT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650664
In the last 90 days, Editas Medicine, Inc. insiders filed 0 open-market purchases and 5 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $386.3M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Editas Medicine, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 251
- −11 vs. Q3 2022
- Shares held
- 54.0M
- +5.96M (+12.4%) vs. Q3 2022
- Total value
- $479.3M
- −$109.1M (−18.5%) vs. Q3 2022
- New holders
- 42
- 64 more added
- Sold out
- 53
- 67 more reduced
3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDIT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 215 | $386.3M |
| Q1 2026 | 208 | $127.5M |
| Q4 2025 | 197 | $102.5M |
| Q3 2025 | 194 | $149.3M |
| Q2 2025 | 194 | $90.9M |
| Q1 2025 | 195 | $51.0M |
| Q4 2024 | 207 | $64.8M |
| Q3 2024 | 230 | $187.7M |
| Q2 2024 | 236 | $263.3M |
| Q1 2024 | 226 | $503.8M |
| Q4 2023 | 226 | $595.7M |
| Q3 2023 | 222 | $481.0M |
| Q2 2023 | 238 | $516.8M |
| Q1 2023 | 236 | $384.0M |
| Q4 2022 | 251 | $479.3M |
| Q3 2022 | 265 | $590.5M |
| Q2 2022 | 258 | $561.5M |
| Q1 2022 | 257 | $862.3M |
| Q4 2021 | 307 | $1.36B |
| Q3 2021 | 321 | $2.17B |
| Q2 2021 | 316 | $2.96B |
| Q1 2021 | 314 | $2.23B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Editas Medicine, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Close Asset Management Ltd | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Maryland Capital Advisors Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Strengthening Families & Communities, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Financial Advocates Investment Management | 0 | $0 | 0.00% | −7,882−100.0% | Sold out |
| Jefferies Group LLC | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |